Cholera toxin potentiates influences of IFN-γ through activation of NF-κB and release of tumor necrosis factor-α

Journal of Interferon and Cytokine Research

Volumn 25, Issue 4, 2005, Pages 209-219

  Blumberg, Richard S ^a   Pitman, Richard S ^a   Taylor, Cormac T ^b   Colgan, Sean P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIBRIO CHOLERAE; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; CELL LINE, TUMOR; CHOLERA TOXIN; DRUG SYNERGISM; GENE EXPRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-6; INTERLEUKIN-8; INTESTINAL MUCOSA; NF-KAPPA B; PERMEABILITY; PROTEIN SUBUNITS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 17144410317     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.209     Document Type: Article

References (65)

1. ELSON, CO., and EALDING, W. (1984). Generalized systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132, 2736-2741.
2. ELSON, C.O., and EALDING, W. (1984). Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133, 2892-2897.
3. ZHANG, R.G., SCOTT, D.L., WESTBROOK, M.L., NANCE, S., SPANGLER, B.D., SHIPLEY, G.G., and WESTBROOK, E.M. (1995). The three-dimensional crystal structure of cholera toxin. J. Mol. Biol. 251, 563-573.
4. GOINS, B., and FREIRE, E. (1988). Thermal stability and inter-subunit interactions of cholera toxin in solution and in association with its cell-surface receptor ganglioside GM1. Biochemistry 27, 2046-2052.
5. CUATRECASAS, P. (1973). Gangliosides and membrane receptors for cholera toxin. Biochemistry 12, 3558-3566.
6. MACKENZIE, C.R., HIRAMA, T., LEE, K.K., ALTMAN, E., and YOUNG, N.M. (1997). Quantitative analysis of bacterial toxin affinity and specificity for glycolipid receptors by surface plasmon resonance. J. Biol. Chem. 272, 5533-5538.
7. LENCER, W.I., and TSAI, B. (2003). The intracellular voyage of cholera toxin: going retro. Trends Biochem. Sci. 28, 639-645.
8. LENCER, W.I., MOE, S., RUFO, P.A., and MADARA, J.L. (1995). Transcylosis of cholera toxin subunits across model human intestinal epithelia. Proc. Natl. Acad. Sci. USA 92, 10094-10098.
9. XU-AMANO, J., KIYONO, H., JACKSON, R.J., STAATS, H.F., FUJIHASHI, K., BURROWS, P.D., ELSON, C.O., PILLAI, S., and McGHEE, J.R. (1993). Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178, 1309-1320.
10. MARINARO, M., STAATS, H.F., HIROI, T., JACKSON, R.J., COSTE, M., BOYAKA, P.N., OKAHASHI, N., YAMAMOTO, M., KIYONO, H., and BLUETHMANN, H. (1995). Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and 1L-4. J. Immunol. 155, 4621-4629.
11. LYCKE, N. (2004). From toxin to adjuvant: the rational design of a vaccine adjuvant vector. CTA1-DD/ISCOM. Cell Microbiol. 6, 23-32.
12. WILLIAMS, N.A., HIRST, T.R., and NASHAR, T.O. (1999). Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol. Today 20, 95-101.
13. DHARMSATHAPHORN, K., MANDEL, K.G., McROBERTS, J., TISDALE, L.D., MASUI, H. (1984). A human colonic tumor cell line that maintains vectorial electrolyte transport. Am. J. Physiol. 246, G204-G208.
14. DHARMSATHAPHORN, K., and MADARA, J.L. (1990). Established intestinal cell lines as model systems for electrolyte transport studies. Methods Enzymol. 192, 354-389.
15. TAYLOR, C.T., DZUS, A.L., and COLGAN, S.P. (1998). Autocrine regulation of intestinal epithelial permeability induced by hypoxia: role for basolateral release of tumor necrosis factor-α (TNF-α). Gastroenterology 114, 657-668.
16. TAYLOR, C.T., FUEKI, N., AGAH, A., HERSHBERG, R.M., and COLGAN, S.P. (1999). Critical role of cAMP response element binding protein expression in hypoxia-elicited induction of epithelial TNFα. J. Biol. Chem. 274, 19447-19450.
17. QUIDING, M., NORDSTROM, I., KILANDER, A., ANDERSSON, G., HANSON, L.A., HOLMGREN, J., and CZERKINSKY, C. (1991). Intestinal immune responses in humans: oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J. Clin. Invest. 88, 143-148.
18. COLGAN, S.P., FURUTA, G.T., and TAYLOR, C.T. (2003). Cytokines and epithelial function. In: Hecht G. ed. Microbial Pathogenesis and the Intestinal Epithelial Cell. G. Hecht (ed.) Washington, DC: ASM Press, pp. 61-78.
19. MADARA, J.L., and STAFFORD, J. (1989). Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83, 724-727.
20. JUNG, H.C., ECKMANN, L., YANG, S.-K., PANJA, A., FIERER, J., MORZYCKA-WROBLEWSKA, E., and KAGNOFF, M.F. (1995). A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95, 55-65.
21. MOREIRA, A.L., SAMPAIO, E.P., ZMUIDZINAS, A., FRINDT, P., SMITH, K.A., and KAPLAN, G. (1993). Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177, 1675-1680.
22. SAMPAIO, E.P., SARNO, E.N., GALILLY, R., COHN, Z., and KAPLAN, G. (1991). Thalidomide selectively inhibits tumor necrosis factor alpha producton by stimulated human monocytes. J. Exp. Med. 173, 699-703.
23. SHARP, G.W., and HYNIE, S. (1971). Stimulation of intestinal adenylcyclase by cholera toxin. Nature 229, 266-269.
24. CASSEL, D., and PFEUFFER, T. (1978). Mechanism of cholera toxin action: covalent modification of the guanyl nucleotide-binding protein of the adenylate cyclase system. Proc. Natl. Acad. Sci. USA 75, 2669-2673.
25. BAEUERLE, P.A. (1991). The inducible transcription activator NF-kappa B: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072, 63-80.
26. KOPP, E.B., and GHOSH, S. (1995). NF-kappa B and Rel proteins in innate immunity. Adv. Immunol. 58, 1-27.
27. GHOSH, S., MAY, M.J., and KOPP, E.B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
28. FUJIKAWA, K. (1992). Synergism between transcription factors NF-IL6 and NF-kappa B in IL-6 gene regulation. Hokkaido Igaku Zasshi 67, 563-574.
29. BEETZ, A., PETER, R.U., OPPEL, T., KAFFENBERGER, W., RUPEC, R.A., MEYER, M., VAN BEUNINGEN, D., KIND, P., and MESSER, G. (2000). NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells. Int. J. Radiat. Biol. 76, 1443-1453.
30. WISSINK, S., VAN DE STOLPE, A., CALDENHOVEN, E., KOENDERMAN, L., and VAN DER SAAG, P.T. (1997). NF-kappa B/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. Immunobiology 198, 50-64.
31. ROY, J., AUDETTE, M., and TREMBLAY, M.J. (2001). Intercellular adhesion molecule-1 (ICAM-1) gene expression in human T cells is regulated by phosphotyrosyl phosphatase activity. Involvement of NF-kappaB, Ets, and palindromic interferon-gamma-responsive element-binding sites. J. Biol. Chem. 276, 14553-14561.
32. SHARMA, S.A., TUMMURU, M.K., BLASER, M.J., and KERR, L.D. (1998). Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J. Immunol. 160, 2401-2407.
33. ROGER, T., OUT, T., MUKAIDA, N., MATSUSHIMA, K., JANSEN, H., and LUTTER, R. (1998). Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells. Biochem. J. 330, 429-435.
34. TREDE, N.S., TSYTSYKOVA, A.V., CHATILA, T., GOLDFELD, A.E., and GEHA, R.S. (1995). Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: role of NF-kappa B. J. Immunol. 155, 902-908.
35. ZIEGLER-HEITBROCK, H.W., STERNSDORF, T., LIESE, J., BELOHRADSKY, B., WEBER, C., WEDEL, A., SCHRECK, R., BAUERLE, P., and STROBEL, M. (1993) Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. J. Immunol. 151, 6986-6993.
36. XIAO, C.W., ASH, K., and TSANG, B.K. (2001). Nuclear factor-kappaB- mediated X-linked inhibitor of apoptosis protein expression prevents rat granulosa cells from tumor necrosis factor alpha-induced apoptosis. Endocrinology 142, 557-563.
37. ABATE, A., OBERLE, S., and SCHRODER, H. (1998). Lipopolysaccharide- induced expression of cyclooxygenase-2 in mouse macrophages is inhibited by chloromethylketones and a direct inhibitor of NF-kappa B translocation. Prostaglandins Other Lipid Mediat. 56, 277-290.
38. PARKOS, C.A., COLGAN, S.P., DIAMOND, M.S., NUSRAT, A., LIANG, T., SPRINGER, T.A., and MADARA, J.L. (1996). Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/18-mediated interactions with neutrophils. Mol. Med. 2, 489-505.
39. HUANG, G.T., ECKMANN, L., SAVIDGE, T.C., and KAGNOFF, M.F. (1996). Infection of human intestinal epithelial cells with invasive bacteria upregulates apical intercellular adhesion molecule-1 (ICAM-1) expression and neutrophil adhesion. J. Clin. Invest. 98, 572-583.
40. ECKMANN, L., JUNG, H.C., SCHURER-MALY, C., PANJA, A., MORZYCKA-WROBLEWSKA, E., and KAGNOFF, M.F. (1993). Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 105, 1689-1697.
41. SCHMITZ, H., FROMM, M., BENTZEL, C.J., SCHOLZ, P., DETJEN, K., MANKERTZ, J., BODE, H., EPPLE, H.J., RIECKEN, E.O., and SCHULZKE, J.D. (1999). Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J. Cell Sci. 112, 137-146.
42. OGATA, H., and PODOLSKY, O.K. (1997). Trefoil peptide expression and secretion is regulated by neuropeptides and acetylcholine. Am. J. Physiol. 273, G348-G354.
43. PODOLSKY, D.K. (1999). Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am. J. Physiol. 277, G495-499.
44. BELL, D., YOUNG, J.W., and BANCHEREAU, J. (1999). Dendritic cells. Adv. Immunol. 72, 255-324.
45. MACPHERSON, G.G., JENKINS, C.D., STEIN, M.J., and EDWARDS, C. (1995). Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J. Immunol. 154, 1317-1322.
46. EBERT, E.C. (1998). Tumour necrosis factor-alpha enhances intraepithelial lymphocyte proliferation and migration. Gut 42, 650-655.
47. PREHN, J.L., LANDERS, C.J., and TARGAN, S.R. (1999). A soluble factor produced by lamina propria mononuclear cells is required for TNF-alpha enhancement of IFN-gamma production by T cells. J. Immunol. 163, 4277-4283.
48. KJERRULF, M., GRDIC, D., EKMAN, L., SCHON, K., VAJDY, M., and LYCKE, N.Y. (1997). Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance. Immunology 92, 60-68.
49. RAVAL, P., OBICI, S., RUSSELL, S.W., and MURPHY, W.J. (1995). Characterization of the 5′ flanking region and gene encoding the mouse interferon-gamma receptor. Gene 154, 219-223.
50. McGEE, D.W., ELSON, C.O., and McGHEE, J.R. (1993). Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines. Infect. Immunol. 61, 4637-4644.
51. BROMANDER, A.K., KJERRULF, M., HOLMGREN, J., and LYCKE, N. (1993). Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. Scand. J. Immunol. 37, 452-458.
52. GOLDSTEIN, H., and KIM, A. (1993). Immunoglobulin secretion and phosphorylation of common proteins are induced by IL-2, IL-4, and IL-6 in the factor responsive human B cell line, SKW6.4. J. Immunol. 151, 6701-6711.
53. GOODRICH, M.E., and McGEE, D.W. (1999). Effect of intestinal epithelial cell cytokines on mucosal B-cell IgA secretion: enhancing effect of epithelial-derived IL-6 but not TGF-beta on IgA + B cells. Immunol. Lett. 67, 11-14.
54. BAGGIOLINI, M., LOETSCHER, P., and MOSER, B. (1995). Interleukin-8 and the chemokine family. Int. J. Immunopharmacol. 17, 103-108.
55. + T cells. J. Leukocyte Biol. 59, 407-411.
56. NISHIURA, H., TANAKA, J., TAKEYA, M., TSUKANO, M., KAMBARA, T., and IMAMURA, T. (1996). IL-8/NAP-1 is the major T-cell chemoattractant in synovial tissues of rheumatoid arthritis. Clin. Immunol. Immunopathol. 80, 179-184.
57. McCORMICK, B.A., HOFMAN, P.M., KIM, J., CARNES, D., MILLER, S.I., and MADARA, J.L. (1995). Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J. Cell Biol. 131, 1599-1608.
58. KAISERLIAN, D., RIGAL, D., ABELLO, J., and REVILLARD, J.P. (1991). Expression, function and regulation of the intercellular adhesion molecule-1 (ICAM-1) on human intestinal epithelial cell lines. Eur. J. Immunol. 21, 2415-2421.
59. MARLIN, S.D. and SPRINGER, T.A. (1987). Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function associated antigen-1 (LFA-1). Cell 51, 813-819.
60. SIEGMUND, B., EIGLER, A., MOELLER, J., GRETEN, T.F., HARTMANN, G., and ENDRES, S. (1997). Suppression of tumor necrosis factor-alpha production by interleukin-10 is enhanced by cAMP-elevating agents. Eur. J. Pharmacol. 321, 231-239.
61. DICKINSON, B.L., and CLEMENTS, J.D. (1995). Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63, 1617-1623.
62. HAN, I.O. KIM, H.S., KIM, H.C., JOE, E.H., and KIM, W.K. (2003). Synergistic expression of inducible nitric oxide synthase by phorbol ester and interferon-gamma is mediated through NF-kappaB and ERK in microglial cells. J. Neurosci. Res. 73, 659-669.
63. SCHUTZE, S., WIEGMANN, K., MACHLEIDT, T., and KRONKE, M. (1995). TNF-induced activation of NF-kappa B. Immunobiology 193, 193-203.
64. SCHUTZE, S., POTTHOFF, K., MACHLEIDT, T., BERKOVIC, D., WIEGMANN, K., and KRONKE, M. (1992). TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71, 765-776.
65. NILSEN, E.M., JOHANSEN, F.E., JAHNSEN, F.L., LUNDIN, K.E., SCHOLZ, T., BRANDTZAEG, P., and HARALDSEN, G. (1998). Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut 42, 635-642.